These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes]. Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M. Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083 [Abstract] [Full Text] [Related]
6. Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Heesom AE, Hibberd ML, Millward A, Demaine AG. Diabetes; 1997 Feb; 46(2):287-91. PubMed ID: 9000706 [Abstract] [Full Text] [Related]
10. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus. Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A. Diabet Med; 2001 Nov; 18(11):906-14. PubMed ID: 11703436 [Abstract] [Full Text] [Related]
11. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients. Lajer M, Tarnow L, Fleckner J, Hansen BV, Edwards DG, Parving HH, Boel E. Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790 [Abstract] [Full Text] [Related]
12. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes. dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. Mol Genet Metab; 2006 Jul; 88(3):280-4. PubMed ID: 16545977 [Abstract] [Full Text] [Related]
13. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. Wu JC, Li XH, Peng YD, Wang JB, Tang JF, Wang YF. J Endocrinol Invest; 2011 Nov; 34(10):e343-8. PubMed ID: 21738003 [Abstract] [Full Text] [Related]
14. Additive effect of aldose reductase Z-4 microsatellite polymorphism and glycaemic control on cataract development in type 2 diabetes. Wang Y, Luk AO, Ng MC, Pang CC, Lam V, Lee SC, Lam DS, Choy KW, Ma RC, So WY, Chan JC. J Diabetes Complications; 2014 Nov; 28(2):147-51. PubMed ID: 24360973 [Abstract] [Full Text] [Related]
15. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. J Diabetes Complications; 2003 Nov; 17(1):1-6. PubMed ID: 12505748 [Abstract] [Full Text] [Related]
17. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al. P K Ng D, Chia KS, Koh D. Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018 [No Abstract] [Full Text] [Related]
20. The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus. Moczulski DK, Burak W, Doria A, Zychma M, Zukowska-Szczechowska E, Warram JH, Grzeszczak W. Diabetologia; 1999 Jan; 42(1):94-7. PubMed ID: 10027585 [Abstract] [Full Text] [Related] Page: [Next] [New Search]